AN2 Therapeutics, Inc.

NasdaqGS:ANTX Stock Report

Market Cap: US$219.2m

AN2 Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ANTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Jul 26SellUS$24,803Joshua EizenIndividual5,945US$4.17
29 May 26SellUS$1,174Sarah WilliamsIndividual265US$4.43
03 Mar 26SellUS$347Sarah WilliamsIndividual327US$1.06
06 Jan 26SellUS$24,962Joshua EizenIndividual24,854US$1.01
06 Jan 26SellUS$9,332Sanjay ChandaIndividual9,251US$1.01
06 Jan 26SellUS$8,883Lucy DayIndividual8,807US$1.01
06 Jan 26SellUS$6,507Stephen PriorIndividual6,462US$1.01
04 Nov 25SellUS$872Stephen PriorIndividual765US$1.14
04 Nov 25SellUS$3,214Joshua EizenIndividual2,819US$1.14

Insider Trading Volume

Insider Buying: ANTX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ANTX?
Owner TypeNumber of SharesOwnership Percentage
Public Companies927,2012.46%
Private Companies1,661,0734.4%
Individual Insiders1,804,2994.78%
General Public3,649,5989.67%
VC/PE Firms5,527,14014.6%
Hedge Funds8,068,27221.4%
Institutions16,098,65442.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 38.1%.

Top Shareholders

Top 25 shareholders own 82.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.36%
Vivo Capital, LLC
3,153,640US$18.3m0%1.47%
7.77%
Commodore Capital LP
2,933,680US$17.0m25.7%0.89%
7.46%
Coastlands Capital LP
2,815,900US$16.4m0%no data
6.29%
Adjuvant Capital, LP
2,373,500US$13.8m0%no data
6.14%
Millennium Management LLC
2,318,692US$13.5m4.33%0.01%
4.41%
BlackRock, Inc.
1,665,494US$9.7m422%no data
4.4%
Spruce Street Capital LP
1,661,073US$9.7m0%no data
3.89%
Almitas Capital LLC
1,469,129US$8.5m-0.68%1.34%
3.8%
Vanguard Capital Management, LLC
1,435,625US$8.3m25%no data
3.5%
Eric Easom
1,321,512US$7.7m0%no data
3.18%
Mountain Group Capital, LLC
1,199,459US$7.0m-2.87%100.0%
2.65%
Adage Capital Management, L.P.
1,000,000US$5.8m0%0.01%
2.52%
Citadel Advisors LLC
951,997US$5.5m513%no data
2.46%
Brii Biosciences Limited
927,201US$5.4m0%no data
1.98%
Boxer Capital Management, LLC
749,035US$4.4m0%0.33%
1.85%
Geode Capital Management, LLC
697,806US$4.1m144%no data
1.58%
Crestline Investors Inc.
597,453US$3.5m0%0.09%
1.47%
Balyasny Asset Management L.P.
556,027US$3.2m0%0.01%
1.46%
Stonepine Capital Management LLC
551,692US$3.2m-22.7%1.33%
1.42%
Columbia Management Investment Advisers, LLC
537,064US$3.1m-22.9%no data
1.4%
Sio Capital Management, LLC
529,933US$3.1m-19.4%0.5%
1.39%
Ally Bridge Group
526,315US$3.1m0%1.24%
1.26%
Prosight Management, LP
474,638US$2.8m-7.97%0.45%
1.22%
Woodline Partners LP
459,805US$2.7m-53.7%0.01%
0.97%
Aldebaran Capital, LLC
367,435US$2.1m-1.17%1.44%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/24 06:28
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AN2 Therapeutics, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Liisa BaykoEvercore ISI
Bradley CaninoGuggenheim Securities, LLC
Joseph SchwartzLeerink Partners LLC